Cipla to Invest upto 100 Million Pounds in UK as Part of Expansion
Pharma major Cipla will invest up to 100 million pounds (nearly Rs 1,030 crore) in UK over next few years for launch and development of new drugs as part of its global footprint expansion plans.
The company will provide high quality affordable medicines to British National Health Service (NHS).
"I am happy to be able to announce that Indian pharmaceutical company Cipla will invest up to GBP 100 million in the UK," a company statement said quoting UK chancellor of the exchequer George Osborne.
He further added the investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral segments.
This will include research and development, clinical trials and further expansion internationally and in the UK.
Commenting on the development, Cipla Board member and global chief financial officer Rajesh Garg said "We are very pleased to be making this investment in the UK. We were impressed with the proactive support and engagement that the UK Government and its various ministries showed in attracting Cipla to choose the UK as a key hub in our global footprint."
The Mumbai based company has portfolio of over 2,000 products in 65 therapeutic categories.
Shares of Cipla on Monday closed at Rs 449.30 per scrip on Bombay Stock Exchange (BSE), up 0.31 per cent from its previous close.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
